DR. JOSEPH KATZ, D.M.D.
Dentist at Archer Rd, Gainesville, FL
License number
Florida DTP 131
Category
Dentist
Type
Dentist
Address
Address
1600 SW Archer Rd, Gainesville, FL 32610
Phone
(352) 273-5800
(352) 392-3070 (Fax)
(352) 392-6797
(352) 392-2507 (Fax)
(352) 392-3070 (Fax)
(352) 392-6797
(352) 392-2507 (Fax)
Organization information
See more information about JOSEPH KATZ at bizstanding.comJoseph Katz DMD
1600 SW Archer Rd, Gainesville, FL 32610
Industry:
Dentists
Phone:
(352) 273-5800 (Phone)
Joseph Katz
Professional information
Dr. Joseph Katz, Gainesville FL - DMD (Doctor of Dental Medicine)
Specialties:
Dentistry
Address:
1600 SW Archer Rd, Gainesville 32610
(352) 273-5800 (Phone), (352) 392-3070 (Fax)
(352) 273-5800 (Phone), (352) 392-3070 (Fax)
Languages:
English
Education:
Medical School
No Information Available As To Scientific Medical Education
No Information Available As To Scientific Medical Education
Joseph Katz, Gainesville FL
Specialties:
Dentist
Address:
1600 Sw Archer Rd, Gainesville, FL 32610
Methods And Kits For Detecting Risk Factors For Development Of Jaw Osteonecrosis And Methods Of Treatment Thereof
US Patent:
2013003, Feb 7, 2013
Filed:
Dec 13, 2010
Appl. No.:
13/520785
Inventors:
Joseph Katz - Gainesville FL, US
Taimour Y. Langaee - Gainesville FL, US
Taimour Y. Langaee - Gainesville FL, US
International Classification:
C40B 30/04, A61P 19/08, A61K 31/675, A61K 31/663, C12Q 1/68, C40B 40/06
US Classification:
514 94, 435 611, 506 9, 506 16, 514108
Abstract:
Methods of and kits for determining the pharmacogenetic, pharmacokinetic and cellular basis of bisphosphonate-induced osteonecrosis of the jaw (BONJ) involve associating particular proteins and particular single nucleotide polymorphisms with a risk for developing BONJ after receiving bisphosphonate treatment. Methods and kits for identifying the genetic basis for a patient's predisposition to BONJ, and methods of identifying patients who are prone to develop BONJ following bisphosphonate administration provide for the development of a tool for physicians to prescribe treatment protocols for BONJ patients based on the patients' genomes (“personal/tailored medicine”). A haplotype tagging SNP approach was used to analyze candidate genes involved in bone absorption and destruction and to examine the influence of genetic variants on the susceptibility of BONJ. Bone biomarkers of BONJ were examined using molecular cell techniques. The methods described herein can be used to identify differences in how patients are genetically predisposed to BONJ as well as genetic differences amongst patients that account for differences in how these patients clear bisphosphonate s from their systems. Determining such genetic differences provides for improved monitoring of the drugs used to treat BONJ, improved prevention of BONJ, and optimized treatment for patients having BONJ or predisposed to BOND.
Methods And Kits For Detecting Risk Factors For Development Of Jaw Osteonecrosis And Methods Of Treatment Thereof
US Patent:
2011016, Jul 7, 2011
Filed:
Jul 7, 2009
Appl. No.:
12/937953
Inventors:
Joseph Katz - Gainesville FL, US
Taimour Y. Langaee - Gainesville FL, US
Taimour Y. Langaee - Gainesville FL, US
Assignee:
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC. - Gainesville FL
International Classification:
A61K 31/663, C12Q 1/68, C40B 30/04, C40B 40/06, A61P 19/08
US Classification:
514108, 435 611, 506 9, 506 16
Abstract:
Methods of and kits for determining the pharmacogenetic, pharmacokinetic and cellular basis of bisphosphonate-induced osteonecrosis of the jaw (BONJ) involve associating particular proteins and particular single nucleotide polymorphisms with a risk for developing BONJ after receiving bisphosphonate treatment. Methods and kits for identifying the genetic basis for a patient's predisposition to BONJ, and methods of identifying patients who are prone to develop BONJ following bisphosphonate administration provide for the development of a tool for physicians to prescribe treatment protocols for BONJ patients based on the patients' genomes (“personal/tailored medicine”).
Compositions And Methods For Detecting Cancers In A Subject
US Patent:
2010004, Feb 25, 2010
Filed:
Jan 31, 2008
Appl. No.:
12/523271
Inventors:
Joseph Katz - Gainesville FL, US
Edward Chan - Gainesville FL, US
Edward Chan - Gainesville FL, US
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
G01N 33/53, C07K 16/18
US Classification:
435 792, 5303891, 435 71
Abstract:
Disclosed are compositions and methods for detecting oral and gastrointestinal cancers in a subject. Autoantigen p90 was shown to be overexpressed in oral cancer cells, and this protein, as well as its companion autoantigen p62 and antibodies directed to both proteins, can be used as markers for detecting oral digestive and other cancers in a subject at an early stage.